Stockreport

Vigil Neuroscience Announces FDA Has Removed Partial Clinical Hold on VG-3927

Vigil Neuroscience, Inc.  (VIGL) 
PDF WATERTOWN, Mass., Sept. 17, 2024 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power [Read more]